You limited your search to:

 Decade: 2000-2009
 Collection: Congressional Research Service Reports
Medicare: Prescription Drug Proposals

Medicare: Prescription Drug Proposals

Date: June 8, 2000
Creator: O'Sullivan, Jennifer
Description: This report provides an overview of the President’s plan and the legislation introduced to date in the 106th Congress. It
Contributing Partner: UNT Libraries Government Documents Department
Medicare: Selected Prescription Drug Proposals

Medicare: Selected Prescription Drug Proposals

Date: September 14, 2000
Creator: O'Sullivan, Jennifer
Description: None
Contributing Partner: UNT Libraries Government Documents Department
Medicare: Side-by-Side Comparison of Selected Prescription Drug Bills

Medicare: Side-by-Side Comparison of Selected Prescription Drug Bills

Date: September 20, 2000
Creator: O'Sullivan, Jennifer & Yacker, Heidi G
Description: None
Contributing Partner: UNT Libraries Government Documents Department
Medicare: Beneficiary Cost-Sharing Under Prescription Drug Legislation

Medicare: Beneficiary Cost-Sharing Under Prescription Drug Legislation

Date: July 25, 2003
Creator: Peterson, Chris L
Description: This report provides an analysis of how the cost-sharing and premium provisions under the Prescription Drug and Medicare Improvement Act of 2003 (S. 1) and the Medicare Prescription Drug and Modernization Act of 2003 (H bill would affect the amount that a beneficiary would pay annually for prescription drugs.
Contributing Partner: UNT Libraries Government Documents Department
Medicare: Beneficiary Cost-Sharing Under Proposed Prescription Drug Benefits

Medicare: Beneficiary Cost-Sharing Under Proposed Prescription Drug Benefits

Date: June 17, 2003
Creator: Peterson, Chris L
Description: This report examines these proposals as well as the “Medicare Rx Drug Benefit and Discount Act of 2003,” which was introduced by Representative Charles Rangel, the ranking member of the House Ways and Means Committee. Specifically, this report provides background on how the cost-sharing and premium provisions under each bill would affect the amount that a beneficiary pays annually for prescription drugs.
Contributing Partner: UNT Libraries Government Documents Department
Medicare: Beneficiary Cost-Sharing Under Proposed Prescription Drug Benefits

Medicare: Beneficiary Cost-Sharing Under Proposed Prescription Drug Benefits

Date: June 26, 2003
Creator: Peterson, Chris L
Description: This report provides background on how the cost-sharing and premium provisions under each bill would affect the amount that a beneficiary pays annually for prescription drugs. In addition, this report gives examples of how annual cost-sharing would differ for beneficiaries with various levels of total prescription drug spending in 2006 under the plans.
Contributing Partner: UNT Libraries Government Documents Department
Medicare Prescription Drug and Reform Legislation

Medicare Prescription Drug and Reform Legislation

Date: June 19, 2003
Creator: O'Sullivan, Jennifer; Chaikind, Hinda Ripps; Tilson, Sibyl L; Boulanger, Jennifer & Morgan, Paulette C
Description: This report describes the major features of S. 1, as ordered reported, and the measure to be considered by the House Ways and Means Committee, H.R. 2473, as ordered reported.
Contributing Partner: UNT Libraries Government Documents Department
Overview of the Medicare Prescription Drug and Reform Legislation

Overview of the Medicare Prescription Drug and Reform Legislation

Date: August 7, 2003
Creator: O'Sullivan, Jennifer; Chaikind, Hinda Ripps; Tilson, Sibyl L; Boulanger, Jennifer & Morgan, Paulette C
Description: None
Contributing Partner: UNT Libraries Government Documents Department
Overview of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003

Overview of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003

Date: April 21, 2004
Creator: O'Sullivan, Jennifer; Chaikind, Hinda Ripps; Tilson, Sibyl L; Boulanger, Jennifer & Morgan, Paulette C
Description: None
Contributing Partner: UNT Libraries Government Documents Department
Medicare Prescription Drug Provisions of S.1, as Passed by the Senate, and H.R. 1, as Passed by the House

Medicare Prescription Drug Provisions of S.1, as Passed by the Senate, and H.R. 1, as Passed by the House

Date: July 11, 2003
Creator: O'Sullivan, Jennifer
Description: This report discusses differences in the specifics of the prescription drug provisions in S. 1 and H.R. 1 and provides a side-by-side comparison of the Title I provisions of both bills.
Contributing Partner: UNT Libraries Government Documents Department
Medicare's Skilled Nursing Facility Benefit

Medicare's Skilled Nursing Facility Benefit

Date: April 16, 2001
Creator: Yacker, Heidi G
Description: None
Contributing Partner: UNT Libraries Government Documents Department
Tobacco Price Support: An Overview of the Program

Tobacco Price Support: An Overview of the Program

Date: November 3, 2003
Creator: Womach, Jasper
Description: None
Contributing Partner: UNT Libraries Government Documents Department
Federal R&D, Drug Discovery, and Pricing: Insights from the NIH-University-Industry Relationship

Federal R&D, Drug Discovery, and Pricing: Insights from the NIH-University-Industry Relationship

Date: June 19, 2000
Creator: Schacht, Wendy H
Description: Interest in methods to provide drugs at lower cost, particularly for the elderly, has rekindled discussion over the role the federal government plays in facilitating the creation of new pharmaceuticals for the marketplace. This report explores the issue of whether or not the substantial federal investment in health-related research and development (R&D) entitles the public to commensurate consideration in prices charged for any resulting drugs. It is intended to provide the reader with an understanding of the rationale for government support of R&D and subsequent efforts to facilitate private sector commercialization of new technologies generated from such work. Concerns surrounding innovation in pharmaceuticals and biotechnology are discussed within the broader context of the federal role in facilitating technological progress.
Contributing Partner: UNT Libraries Government Documents Department
Medical Records Privacy: Questions and Answers on the HIPAA Final Rule

Medical Records Privacy: Questions and Answers on the HIPAA Final Rule

Date: September 10, 2001
Creator: Redhead, C. Stephen
Description: This report discusses the issue facing Congress on whether to continue to support the executive branch’s prosecution of medical marijuana patients and their providers, in accordance with marijuana’s status as a Schedule I drug under the Controlled Substances Act, or whether to relax federal marijuana prohibition enough to permit the medical use of botanical cannabis products by seriously ill persons, especially in states that have created medical marijuana programs under state law.
Contributing Partner: UNT Libraries Government Documents Department
Medical Records Privacy: Questions and Answers on the HIPAA Final Rule

Medical Records Privacy: Questions and Answers on the HIPAA Final Rule

Date: October 3, 2002
Creator: Redhead, C. Stephen
Description: This report discusses the issue facing Congress on whether to continue to support the executive branch’s prosecution of medical marijuana patients and their providers, in accordance with marijuana’s status as a Schedule I drug under the Controlled Substances Act, or whether to relax federal marijuana prohibition enough to permit the medical use of botanical cannabis products by seriously ill persons, especially in states that have created medical marijuana programs under state law.
Contributing Partner: UNT Libraries Government Documents Department
Medical Records Privacy: Questions and Answers on the HIPAA Final Rule

Medical Records Privacy: Questions and Answers on the HIPAA Final Rule

Date: January 3, 2003
Creator: Redhead, C. Stephen
Description: This report discusses the issue facing Congress on whether to continue to support the executive branch’s prosecution of medical marijuana patients and their providers, in accordance with marijuana’s status as a Schedule I drug under the Controlled Substances Act, or whether to relax federal marijuana prohibition enough to permit the medical use of botanical cannabis products by seriously ill persons, especially in states that have created medical marijuana programs under state law.
Contributing Partner: UNT Libraries Government Documents Department
Medical Records Privacy: Questions and Answers on the HIPAA Final Rule

Medical Records Privacy: Questions and Answers on the HIPAA Final Rule

Date: June 11, 2003
Creator: Redhead, C. Stephen
Description: This report discusses the issue facing Congress on whether to continue to support the executive branch’s prosecution of medical marijuana patients and their providers, in accordance with marijuana’s status as a Schedule I drug under the Controlled Substances Act, or whether to relax federal marijuana prohibition enough to permit the medical use of botanical cannabis products by seriously ill persons, especially in states that have created medical marijuana programs under state law.
Contributing Partner: UNT Libraries Government Documents Department
Medical Records Privacy: Questions and Answers on the HIPAA Final Rule

Medical Records Privacy: Questions and Answers on the HIPAA Final Rule

Date: March 10, 2004
Creator: Redhead, C. Stephen
Description: This report discusses the issue facing Congress on whether to continue to support the executive branch’s prosecution of medical marijuana patients and their providers, in accordance with marijuana’s status as a Schedule I drug under the Controlled Substances Act, or whether to relax federal marijuana prohibition enough to permit the medical use of botanical cannabis products by seriously ill persons, especially in states that have created medical marijuana programs under state law.
Contributing Partner: UNT Libraries Government Documents Department
The Hatch-Waxman Act: Proposed Legislative Changes

The Hatch-Waxman Act: Proposed Legislative Changes

Date: September 3, 2002
Creator: Schacht, Wendy H & Thomas, John R
Description: None
Contributing Partner: UNT Libraries Government Documents Department
The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents

The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents

Date: November 25, 2002
Creator: Schacht, Wendy H & Thomas, John R
Description: None
Contributing Partner: UNT Libraries Government Documents Department
The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents

The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents

Date: January 16, 2003
Creator: Schacht, Wendy H & Thomas, John R
Description: None
Contributing Partner: UNT Libraries Government Documents Department
The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents

The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents

Date: April 2, 2003
Creator: Schacht, Wendy H & Thomas, John R
Description: None
Contributing Partner: UNT Libraries Government Documents Department
The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents

The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents

Date: May 8, 2003
Creator: Schacht, Wendy H & Thomas, John R
Description: None
Contributing Partner: UNT Libraries Government Documents Department
The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents

The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents

Date: June 23, 2003
Creator: Schacht, Wendy H & Thomas, John R
Description: None
Contributing Partner: UNT Libraries Government Documents Department
FIRST PREV 1 2 3 4 5 NEXT LAST